Tag: Aducanumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aducanumab

Undervalued by 28%, This Stock Is a Buy for Patient Investors - Morningstar

Added to Collection on: 2024-05-21 15:25:38

Tags for this article:

Orphan drugs
Spinal muscular atrophy
Specialty drugs
Biogen
Interferon beta-1a
Multiple sclerosis
Biosimilar
Dimethyl fumarate
Rituximab
Aducanumab
Natalizumab
Lecanemab
United States
Tysabri

Click the tags to see associated articles and topics

View Article Details
FDA advisors unanimously back Lilly's Alzheimer's drug - BioProcess International

Added to Collection on: 2024-06-11 15:42:17

Tags for this article:

Orphan drugs
Aducanumab
Donanemab
Alzheimer's disease
Lecanemab
Accelerated approval
Biogen
Surrogate endpoint

Click the tags to see associated articles and topics

View Article Details
Alzheimer's Disease Drug Donanemab Gets Backing From FDA Expert Panel - Forbes

Added to Collection on: 2024-06-11 14:37:29

Tags for this article:

Alzheimer's disease
Amyloidosis
Biomarkers
Donanemab
Orphan drugs
Aducanumab
Lecanemab
Amyloid beta
Amyloid plaques
Bapineuzumab

Click the tags to see associated articles and topics

View Article Details
Lilly drug for Alzheimer's approved by FDA | BioPharma Dive

Added to Collection on: 2024-07-02 18:38:49

Tags for this article:

Biogen
Spinal muscular atrophy
Aducanumab
Orphan drugs
Donanemab
Alzheimer's disease
Lecanemab
Accelerated approval
Eli Lilly and Company
Eisai
Alzheimer's Drug Discovery Foundation
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Mirae Asset Global Investments Co. Ltd. Sells 6396 Shares of Biogen Inc. (NASDAQ:BIIB)

Added to Collection on: 2024-07-07 19:49:30

Tags for this article:

Spinal muscular atrophy
Biogen
Aducanumab
Interferon beta-1a
Short

Click the tags to see associated articles and topics

View Article Details
Side Effects of the New Alzheimer's Drugs - MedShadow Foundation

Added to Collection on: 2024-07-11 17:27:37

Tags for this article:

Amyloidosis
Alzheimer's disease
Histopathology
Donanemab
Aducanumab
Biogen
Lecanemab
Amyloid beta
Accelerated approval
Amyloid plaques
Amyloid
Carol Jennings
Peter Whitehouse
Case Western Reserve University
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
HCPLive Year in Review: Top 10 FDA Approvals for 2024

Added to Collection on: 2024-12-31 15:02:06

Tags for this article:

Peptide hormones
PEPTIDE THERAPEUTICS
In Denmark
In science
Semaglutide
Anti-obesity medication
Tirzepatide
Dupilumab
Donanemab
Xanomeline/trospium chloride
Metabolic dysfunction–associated steatotic liver disease
Aducanumab
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Monoclonal antibodies: are they the key to treating Alzheimer's disease? - Labiotech

Added to Collection on: 2025-02-10 14:01:00

Tags for this article:

Immunology
Lecanemab
Bapineuzumab
Donanemab
Amyloid-related imaging abnormalities
Alzheimer's disease
Trontinemab
Monoclonal antibody
Aducanumab
Biogen
Draft:Eisai's Alzheimers Trial
Carol Jennings
United States

Click the tags to see associated articles and topics

View Article Details
EU's CHMP Reaffirms Positive Opinion of Alzheimer Treatment Lecanemab - NeurologyLive

Added to Collection on: 2025-03-08 16:05:14

Tags for this article:

Orphan drugs
Lecanemab
Alzheimer's disease
Amyloidosis
Aducanumab
Donanemab
Eisai
Biogen
Amyloid plaques
Anti-amyloid drugs

Click the tags to see associated articles and topics

View Article Details
Leerink Partnrs Estimates Biogen's Q2 Earnings (NASDAQ:BIIB) - Defense World

Added to Collection on: 2025-04-16 05:40:14

Tags for this article:

Financial ratios
Corporate finance
Spinal muscular atrophy
Biogen
Equity securities
Fundamental analysis
Price?earnings ratio
Earnings per share
Aducanumab
Short
Interferon beta-1a
Dividend
Biogen Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo